-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5

Benzinga·08/07/2026 21:09:37
Listen to the news
TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.